| Association of plasma circulating tumor HPV DNA with HPV-related oropharynx cancer SR Tewari, G D’Souza, T Troy, H Wright, L Struijk, T Waterboer, C Fakhry JAMA Otolaryngology–Head & Neck Surgery 148 (5), 488-489, 2022 | 14 | 2022 |
| Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time N Scott‐Wittenborn, G D'Souza, S Tewari, L Rooper, T Troy, V Drake, ... Cancer 128 (9), 1767-1774, 2022 | 9 | 2022 |
| Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections C Fakhry, N Fung, SR Tewari, G D'Souza Oral oncology 111, 104981, 2020 | 7 | 2020 |
| Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study G D’Souza, SR Tewari, T Troy, T Waterboer, L Struijk, R Castillo, H Wright, ... Cancer 129 (15), 2373-2384, 2023 | 3 | 2023 |
| Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years G D'Souza, SR Tewari, T Troy, J Webster-Cyriaque, DJ Wiley, CD Lahiri, ... Cancer Epidemiology, Biomarkers & Prevention, OF1-OF9, 2024 | 2 | 2024 |
| Mitochondrial DNA copy number is associated with incident chronic kidney disease and proteinuria in the AIDS linked to the intravenous experience cohort SR Tewari, GD Kirk, DE Arking, J Astemborski, C Newcomb, DA Piggott, ... Scientific Reports 13 (1), 18406, 2023 | | 2023 |
| Feasibility of clinical evaluation of individuals with increased risk for HPV‐associated oropharynx cancer N Scott‐Wittenborn, G D'Souza, N Aygun, SR Tewari, J Azadi, P Vosler, ... Head & neck 45 (1), 95-102, 2023 | | 2023 |
| RTOG‐0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort C Fakhry, SR Tewari, L Zhang, MJ Windon, EO Bigelow, VE Drake, ... Cancer 127 (19), 3523-3530, 2021 | | 2021 |
